Literature DB >> 31665649

Resistance to BET Inhibitor Leads to Alternative Therapeutic Vulnerabilities in Castration-Resistant Prostate Cancer.

Aishwarya Pawar, Paradesi Naidu Gollavilli, Shaomeng Wang, Irfan A Asangani.   

Abstract

Entities:  

Year:  2019        PMID： 31665649     DOI： 10.1016/j.celrep.2019.10.037

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


× No keyword cloud information.
  2 in total

Review 1.  The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials.

Authors:  Mingyue Xia; Zhigang Guo; Zhigang Hu
Journal:  Biomolecules       Date:  2021-05-12

2.  Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition.

Authors:  Florencia Paula Madorsky Rowdo; Antonela Barón; Stuart John Gallagher; Peter Hersey; Abdullah Al Emran; Erika M Von Euw; María Marcela Barrio; José Mordoh
Journal:  Int J Oncol       Date:  2020-03-30       Impact factor: 5.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.